Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Good info in MD&A

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon May 30, 2022 8:11pm

240 Views

Post# 34718572

RE:Good info in MD&A

The key is the Optimized group, those first 12 shouldn't count, IMO. I think the market will take that into account. A chemo disrupter? I think so eventually, one can dream. Still need to see how it does in other indications, against solid tumors, etc....

livermore2 wrote: Seems the optimized patients are trending in the right direction! Looks like a chemotherapy disrupter on our hands here!!

Lets see how the market reacts in the am.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec